Alterity Therapeutics Ltd SEC filings PRNAF
Alterity Therapeutics Ltd has 1,000 filings in SEC EDGAR's recent list, going back to Oct 22, 2007. Its latest annual report, Form 20-F, was filed on Aug 28, 2026 for the period ended Jun 30, 2026. The most recent current report (Form 6-K) was filed on Oct 30, 2026. The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Sep 18, 2026 | — |
| 424B5 | Prospectus supplement | Feb 15, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Oct 2, 2023 | — |
| 424B3 | Prospectus | Jan 6, 2021 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 23, 2020 | — |
| 424B5 | Prospectus supplement | Dec 16, 2020 | — |
| S-8 | Employee stock plan registration | Dec 2, 2020 | — |
| 424B3 | Prospectus | Nov 23, 2020 | — |
| F-3 | Shelf registration (foreign issuer) | Nov 13, 2020 | — |
| F-3 | Shelf registration (foreign issuer) | Oct 5, 2020 | — |
| S-8 | Employee stock plan registration | Sep 23, 2020 | — |
| 424B3 | Prospectus | May 22, 2019 | — |
| F-3 | Shelf registration (foreign issuer) | May 13, 2019 | — |
| 424B3 | Prospectus | Apr 10, 2019 | — |
| S-8 | Employee stock plan registration | Dec 4, 2018 | — |
| 424B5 | Prospectus supplement | Nov 8, 2017 | — |
| F-3 | Shelf registration (foreign issuer) | Oct 10, 2017 | — |
| 424B5 | Prospectus supplement | Oct 13, 2016 | — |
| 424B5 | Prospectus supplement | Nov 26, 2014 | — |
| F-6EF | Form f-6 | Nov 6, 2014 | — |
| F-3 | Shelf registration (foreign issuer) | Nov 3, 2014 | — |
| POS AM | Deregistration of securities under 333-190908 and 174278 | Jul 24, 2014 | — |
| 424B5 | Prospectus supplement | Aug 30, 2013 | — |
| 424B5 | Prospectus supplement | Aug 30, 2013 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 30, 2013 | — |
| FWP | Free writing prospectus | Sep 19, 2011 | — |
| 424B5 | Prospectus supplement | Jul 13, 2011 | — |
| F-3 | Shelf registration (foreign issuer) | May 17, 2011 | — |
| 424B3 | Prospectus | Apr 21, 2011 | — |
| F-3 | Shelf registration (foreign issuer) | Apr 8, 2011 | — |
| 424B3 | Prospectus | Oct 6, 2009 | — |
| F-3 | Shelf registration (foreign issuer) | Sep 25, 2009 | — |
| POS AM | Filing | Aug 5, 2009 | — |
| 424B3 | Prospectus | Oct 17, 2008 | — |
| S-8 | Employee stock plan registration | Sep 25, 2008 | — |
| 424B1 | Filing | Mar 10, 2008 | — |
| POS AM | Filing | Feb 28, 2008 | — |
| F-6 POS | Post effective amend no. 1 | Dec 21, 2007 | — |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ATHE (Nasdaq), PRNAF (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- Australia
- Headquarters
- Melbourne
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1131343
- Former names
- PRANA BIOTECHNOLOGY LTD (until Apr 8, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.